1 day Ago By ABMN Staff
Cutera, Inc. ( NASDAQ:CUTR – Get Free Report ) saw a large decline in short interest in August. As of August 31st, there was short interest totalling 3,930,000 shares, a decline of 10.
3% from the August 15th total of 4,380,000 shares. Based on an average daily trading volume, of 556,900 shares, the short-interest ratio is currently 7.1 days.
Cutera Stock Performance Shares of CUTR stock traded up $0.01 during trading hours on Wednesday, reaching $0.76.
The company had a trading volume of 205,076 shares, compared to its average volume of 1,052,249. Cutera has a 12-month low of $0.65 and a 12-month high of $9.
12. The company has a market capitalization of $15.32 million, a price-to-earnings ratio of -0.
11 and a beta of 1.32. The stock has a fifty day moving average of $1.
04 and a 200-day moving average of $1.62. Cutera ( NASDAQ:CUTR – Get Free Report ) last released its quarterly earnings data on Thursday, August 8th.
The medical device company reported ($1.23) EPS for the quarter, beating analysts’ consensus estimates of ($1.55) by $0.
32. The business had revenue of $34.38 million during the quarter, compared to analyst estimates of $39.
47 million. On average, analysts forecast that Cutera will post -5.13 EPS for the current year.
Analyst Upgrades and Downgrades View Our Latest Analysis on CUTR Institutional Inflows and Outflows Large investors have recently added to or reduced their stakes in the business. Opti Capital Management LP acquired a new position in Cutera in the fourth quarter valued at approximately $1,755,000,000. Dynamic Technology Lab Private Ltd acquired a new position in Cutera during the fourth quarter worth $102,000.
Bayesian Capital Management LP acquired a new position in Cutera during the first quarter worth $33,000. Findell Capital Management LLC acquired a new position in Cutera during the fourth quarter worth $39,000. Finally, Ground Swell Capital LLC acquired a new position in Cutera during the second quarter worth $37,000.
90.70% of the stock is currently owned by institutional investors and hedge funds. About Cutera ( Get Free Report ) Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide.
It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. Featured Articles Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.
com's FREE daily email newsletter ..
